| Direct Competitor Comparison | |
|---|
| TEVA | ACT | PVT1 | PVT2 | Industry |
|---|
| Market Cap: | 34.26B | 16.63B | N/A | N/A | 32.64B |
|---|
| Employees: | 45,948 | 17,700 | 14,0421 | N/A | 35.15K |
|---|
| Qtrly Rev Growth (yoy): | -0.04 | 0.24 | N/A | N/A | 1.74 |
|---|
| Revenue (ttm):
| 20.12B | 6.29B | 1.86B1 | N/A | 13.93B |
|---|
| Gross Margin (ttm): | 0.53 | 0.47 | N/A | N/A | 0.83 |
|---|
| EBITDA (ttm): | 5.72B | 1.45B | N/A | N/A | 5.72B |
|---|
| Operating Margin (ttm):
| 0.21 | 0.13 | N/A | N/A | 0.20 |
|---|
| Net Income (ttm): | 1.73B | -60.30M | -528.80M1 | N/A | N/A |
|---|
| EPS (ttm): | 2.00 | -0.48 | N/A | N/A | 2.00 |
|---|
| P/E (ttm): | 20.07 | N/A | N/A | N/A | 24.04 |
|---|
| PEG (5 yr expected): | 1.26 | 1.02 | N/A | N/A | 1.15 |
|---|
| P/S (ttm): | 1.70 | 2.58 | N/A | N/A | 3.04 |
|---|
|
| ACT = Actavis, Inc. | | Pvt1 = Ranbaxy Laboratories Limited | | Pvt2 = Sandoz International GmbH (privately held) | | Industry = Drug Manufacturers - Other | | 1 = As of 2011 |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 104.24 | 0.02 | 78.18B | 17.64 |
|---|
| Genentech, Inc. | Private |
|---|
| Biogen Idec Inc. | BIIB | 231.33 | 0.03 | 54.91B | 36.71 |
|---|
| Genzyme Corporation | Private |
|---|
| Merck Serono S.A. | Private |
|---|
| Gilead Sciences Inc. | GILD | 56.47 | 0.01 | 86.14B | 31.62 |
|---|
| MedImmune, L.L.C. | Private |
|---|
| Life Technologies Corporation | LIFE | 73.68 | 0.00 | 12.68B | 31.19 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.21 | 0.00 | 34.26B | 20.07 |
|---|
| Sandoz International GmbH | Private |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 130.20 | 0.02 | 16.63B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private |
|---|
| Mylan, Inc. | MYL | 31.23 | -0.00 | 11.90B | 20.86 |
|---|
| Pfizer Inc. | PFE | 28.78 | 0.00 | 204.14B | 13.78 |
|---|
| Johnson & Johnson | JNJ | 88.59 | 0.01 | 248.84B | 24.06 |
|---|
| GlaxoSmithKline plc | GSK | 52.65 | 0.01 | 127.52B | 19.24 |
|---|
| Sanofi | SNY | 55.05 | 0.02 | 145.70B | 27.13 |
|---|
| Novartis AG | NVS | 74.63 | 0.01 | 183.38B | 18.94 |
|---|
| Roche Holding AG | RHHBY | 64.71 | 0.02 | 219.62B | 21.66 |
|---|
| AstraZeneca PLC | AZN | 51.71 | 0.00 | 64.64B | 11.44 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.72 | -0.00 | 58.80B | 11.50 |
|---|
| Bristol-Myers Squibb Company | BMY | 44.06 | 0.01 | 72.37B | 49.90 |
|---|
|
| News on Direct Competitors | |
|---|
Currency in USD. | |
|
0.30%